Newsroom

NEW YORK--(BUSINESS WIRE)--TPG Mortgage Investment Trust, Inc. (NYSE: MITT) (the “Company”) announced today that its Board of Directors declared a dividend of $0.24 per common share for the second quarter 2026. The dividend is payable on July 31, 2026, to shareholders of record at the close of business on June 30, 2026. About TPG Mortgage Investment Trust, Inc. TPG Mortgage Investment Trust, Inc. is a residential mortgage REIT with a focus on investing in a diversified risk-adjusted portfolio o...

BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced its participation in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026, taking place June 23–24, 2026. President and Chief Executive Officer Paul Gudonis and Chief Financial Officer David Henry will deliver a presentati...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...

LAS VEGAS--(BUSINESS WIRE)--MP Materials Corp. (NYSE: MP) today announced that Ryan Corbett, Chief Financial Officer, will participate in the J.P. Morgan Natural Resources Conference on Tuesday, June 23, 2026, at 8:35 a.m. Eastern Time.A live webcast and replay will be available at https://investors.mpmaterials.com/.About MP MaterialsMP Materials (NYSE: MP) is America’s only fully integrated rare earth producer with capabilities spanning the entire supply chain—from mining and processing to adva...

FREMONT, Calif.--(BUSINESS WIRE)--Penguin Solutions announced its quarterly financial webcast and conference call for Q3 FY2026 earnings after market close on Tues July 7 at 1:30 pm PT...

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced the publication of a new analysis from the Kidney Allograft Outcomes AlloSure Registry (KOAR), a landmark multi-center study, in the Journal of the American Society of Nephrology (JASN). The se...

DANA POINT, Calif.--(BUSINESS WIRE)--CareTrust REIT Announces Quarterly Dividend of $0.39 per Share...

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that on June 15, 2026, inducement grants (the “Inducement Grants”) were made to three employees in connection with the commencement of their employment. The Inducement Grants consisted of 336,804 restricted stock units (“RSUs”) representing 336,804 shares of Quanterix commo...

BOSTON--(BUSINESS WIRE)--Verastem doses first patient in TARGET-D 201, a registration-directed Phase 2 trial of VS-7375 in KRAS G12D-mutated advanced pancreatic cancer...

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on June 15, 2026, it granted stock options to purchase an aggregate of 103,020 shares of common stock to nine n...